Trials / Completed
CompletedNCT04077567
An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 401 (actual)
- Sponsor
- Taisho Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the long-term safety and efficacy of TS-152 in subjects with Rheumatoid Arthritis who have completed the previous study (TS152-3000-JA study or TS152-3001-JA study).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TS-152 | 30mg,80mg |
Timeline
- Start date
- 2019-10-01
- Primary completion
- 2023-04-28
- Completion
- 2023-04-28
- First posted
- 2019-09-04
- Last updated
- 2025-02-28
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04077567. Inclusion in this directory is not an endorsement.